Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, Kuchibhotla U, Moyers JS, Benson CT, Gimeno RE, DAlessio DA, Haupt A (2018) LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept
The relationship between homocysteine and thrombosis in line with present scientific literature is elaborated in this review with a major focus on homocysteine-induced thrombotic events in infections, with the example of COVID-19 and sepsis
Whilst further research is needed, it is promising that there is some indication that GLP-1s may form part of binge eating disorder treatment in years to come
There are many benefits of GLP certification